SALT LAKE CITY, May 26, 2010 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Peter D. Meldrum, President and CEO, is scheduled to present at the GARP Research and Securities Company Investor Conference, at 9:30 a.m. Eastern on June 9, 2010, at the Marriott Waterfront Hotel in Baltimore, Maryland.
